Literature DB >> 20528235

Male breast cancer.

Stefano Zurrida1, Franco Nolè, Bernardo Bonanni, Mauro Giuseppe Mastropasqua, Paolo Arnone, Oreste Gentilini, Antuono Latronico.   

Abstract

Diagnosis and treatment modalities for female breast cancer have developed spectacularly in recent years. Unfortunately, this is not the case for male breast cancer. Because the disease is so rare, controlled clinical trials have almost never been performed and treatment is based on findings in women or small series of men. Similarly, while breast cancer in women is diagnosed at an increasingly early stage, male breast cancer is usually diagnosed late, when the chances of cure are diminished. This article reviews what is currently known about male breast cancer, with an emphasis on areas where evidence-based data are scarce. While it is possible that some recent developments in female breast cancer treatment could be applicable to men, but the way forward is to increase awareness of the disease, and for treatment centers to pool patients for inclusion in randomized clinical trials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528235     DOI: 10.2217/fon.10.55

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  1 in total

1.  Clinicopathological characteristics and survival outcomes of male breast cancer according to race: A SEER population-based study.

Authors:  He-Fen Sun; Yang Zhao; Shui-Ping Gao; Liang-Dong Li; Wen-Yan Fu; Hong-Lin Jiang; Meng-Ting Chen; Li-Peng Yang; Wei Jin
Journal:  Oncotarget       Date:  2017-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.